⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EVGN News
EVOGENE LTD.
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
globenewswire.com
EVGN
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
prnewswire.com
EVGN
Artificial Intelligence in Drug Repurposing Global Market Research Report 2025 with Long-term Prospects to 2029 and 2034
globenewswire.com
IBM
EVGN
DNA
RXRX
COSM
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
prnewswire.com
EVGN
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development
prnewswire.com
EVGN
Evogene Reports Third Quarter 2025 Financial Results
prnewswire.com
EVGN
Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming
prnewswire.com
EVGN
Evogene Schedules Third Quarter 2025 Financial Results Release
prnewswire.com
EVGN